Skip to content
GLP-1 Savers
Menu

Head-to-head · Value Score

Alan Meds vs PrescribedRX

Two GLP-1 deals, scored on the same six factors. Alan Meds lands a Value Score of 90, PrescribedRX a 62. Here's who gives you the honest lower price — and where each one bites back.

★ Better value

Alan Meds

#7 · Grade A · Best Value

Est. first month

$99/mo

Save ~93% vs brand-name
Get this deal Full Alan Meds review →
VS

PrescribedRX

#351 · Grade C · Watch List

Est. first month

From $189/mo (compounded)

Save ~86% vs brand-name
Get this deal Full PrescribedRX review →

The verdict

Better value: Alan Meds

Alan Meds takes it on Value Score, 90 to 62 an est. $99/mo first month, with no teaser step-up baked in. PrescribedRX isn't out of it: People who want compounded GLP-1 weight loss inside a broader men's and women's telehealth brand.

Our #1 overall:Neither of these is our top pick — that's CoreAge Rx (Value Score 93).See why →

Deal-by-deal

The numbers that decide it. Green ✓ marks the stronger side on each line.

DealAlan MedsPrescribedRX
Value Score90 (A)62 (C)
Est. first month$99/moFrom $189/mo (compounded)
Save vs brand-name~93%~86%
Semaglutide$99/moFrom $189/mo (compounded)
Tirzepatide$145/moFrom $276/mo (compounded)
Both moleculesYesYes
PricingFlat — no step-upWatch
CoverageAll 50 statesCoverage not published

Factor by factor

The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.

95
Lowest Real Price
74
Alan Meds: 95. PrescribedRX: 74.
85
No Teaser-Rate Bait
28
Alan Meds: 85. PrescribedRX: 28.
98
Nationwide Availability
45
Alan Meds: 98. PrescribedRX: 45.
94
Both Molecules
92
Alan Meds: 94. PrescribedRX: 92.
82
Easy Cancellation
68
Alan Meds: 82. PrescribedRX: 68.
72
Reputation
63
Alan Meds: 72. PrescribedRX: 63.

Alan Meds

Double-digit semaglutide ($99) and a $145 tirzepatide, both nationwide, with an oral route for the needle-shy.

Why it's a deal

  • $99 flat semaglutide and a low $145 tirzepatide
  • Available in all 50 states
  • Offers an oral/sublingual route

The fine print

  • Not LegitScript-certified — do your own pharmacy diligence
  • Newer operator with a thin public track record

PrescribedRX

PrescribedRX is a multi-condition telehealth brand (TRT, longevity, hair loss, sexual health and weight loss) that prescribes compounded GLP-1 injectables for weight loss: semaglutide at $189/month and…

Why it's a deal

  • Compounded semaglutide ($189/mo) and tirzepatide ($276/mo) injectables, with lower per-month pricing on the 3-month plans ($176 and $233/mo)
  • Clear, upfront plan pages showing monthly and multi-month pricing with no surprise fees
  • Care from licensed US providers with monthly home delivery and ongoing dose support
  • Bilingual English/Spanish site and a broader telehealth menu (TRT, longevity, hair, sexual health) for people who want more than weight loss

The fine print

  • Doesn't publish the states it serves — you only learn eligibility after starting the intake
  • Compounding pharmacies aren't named on the site
  • Mid-range pricing — cheaper compounded GLP-1 options exist and the 3-month discount is modest
  • Compounded semaglutide and tirzepatide injectables only — no brand-name or oral options
  • Self-hosted affiliate program (not a vetted network); Florida/Palm Beach framing suggests a regional lean
Get the Alan Meds deal Get the PrescribedRX deal

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.

Neither one the right fit? Every program that outscores Alan Meds is ranked on the Alan Meds alternatives board, and the same list for the other side is on alternatives to PrescribedRX.

More head-to-heads

← All comparisons

Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.